NCT07281417 2026-05-22Testing the Addition of Cemiplimab (REGN2810) to Chemotherapy Treatment Given Prior to Surgery in Patients With Sinonasal Squamous Cell CarcinomaNational Cancer Institute (NCI)Phase 2 Recruiting108 enrolled